- Report
- May 2025
- 120 Pages
Global
From €4218EUR$4,750USD£3,685GBP
- Report
- September 2025
- 250 Pages
Global
From €3988EUR$4,490USD£3,483GBP
- Report
- September 2025
- 250 Pages
Global
From €3988EUR$4,490USD£3,483GBP
- Report
- September 2025
- 250 Pages
Global
From €3988EUR$4,490USD£3,483GBP
- Report
- September 2025
- 250 Pages
Global
From €3988EUR$4,490USD£3,483GBP
- Report
- September 2025
- 250 Pages
Global
From €3988EUR$4,490USD£3,483GBP
- Report
- September 2025
- 250 Pages
Global
From €3988EUR$4,490USD£3,483GBP
- Report
- April 2025
- 175 Pages
Global
From €3988EUR$4,490USD£3,483GBP
- Report
- April 2025
- 175 Pages
Global
From €3988EUR$4,490USD£3,483GBP
- Report
- January 2025
- 175 Pages
Global
From €3988EUR$4,490USD£3,483GBP
- Report
- December 2025
- 467 Pages
Global
From €5195EUR$5,850USD£4,539GBP
- Report
- December 2025
- 468 Pages
Global
From €5195EUR$5,850USD£4,539GBP
- Report
- December 2025
- 390 Pages
Global
From €5195EUR$5,850USD£4,539GBP
- Report
- December 2025
- 266 Pages
Global
From €5195EUR$5,850USD£4,539GBP
- Report
- December 2025
- 573 Pages
Global
From €5195EUR$5,850USD£4,539GBP
- Report
- December 2025
- 372 Pages
Global
From €5195EUR$5,850USD£4,539GBP
- Report
- December 2025
- 279 Pages
Global
From €5195EUR$5,850USD£4,539GBP
- Report
- December 2025
- 578 Pages
Global
From €5195EUR$5,850USD£4,539GBP
- Report
- December 2025
- 360 Pages
Global
From €5195EUR$5,850USD£4,539GBP
- Report
- December 2025
- 372 Pages
Global
From €5195EUR$5,850USD£4,539GBP

The Vaccine Manufacturing market is a subset of the biopharmaceutical industry, which focuses on the development and production of vaccines. Vaccines are biological products that are used to prevent and treat infectious diseases. Vaccine manufacturing involves the production of active ingredients, such as antigens, as well as the formulation and packaging of the final product. Vaccine manufacturers must adhere to strict regulatory standards to ensure the safety and efficacy of their products.
The Vaccine Manufacturing market is highly competitive, with a number of large pharmaceutical companies and biotechnology firms competing for market share. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more